Melatonin Side Effects: Scientific Evidence of Morning Cognitive Impairment and a Rational Usage Guide

Introduction: The Over-Mythologized Sleep Supplement

Melatonin, as an over-the-counter sleep supplement, has seen continuously rising global usage in recent years. Many people regard it as a "universal key" for solving insomnia, overcoming jet lag, and adjusting sleep schedules—some even take it daily as a long-term health supplement. However, a study on healthy young adults has thrown cold water on this trend: melatonin may impair users' cognitive function the following morning.

This finding deserves attention not only because it challenges the widespread public perception that melatonin is "safe and harmless," but also because it reveals a commonly overlooked problem—the disruption of the body's natural physiological rhythms by supplementing exogenous hormones may carry side effects we have yet to fully understand.

Melatonin and the Biological Clock: Mechanisms of Morning Cognitive Impairment

How Melatonin Regulates Circadian Rhythm

Melatonin is fundamentally a hormone secreted by the pineal gland, with its core function being to signal the body that "night has arrived," thereby regulating the circadian rhythm. Under normal conditions, the body begins secreting melatonin in the evening, with concentrations peaking in the middle of the night and gradually declining toward morning, preparing the body for waking and entering an alert state.

At the molecular level, melatonin synthesis begins with the essential amino acid tryptophan, which undergoes a series of enzymatic reactions including hydroxylation and decarboxylation, first converting to serotonin, then being catalyzed by N-acetyltransferase (NAT) and hydroxyindole-O-methyltransferase (HIOMT) to ultimately synthesize melatonin in the pineal gland. In the body, melatonin is primarily metabolized by the liver enzyme CYP1A2, with a physiological half-life of approximately 40–60 minutes. However, when exogenous supplementation doses far exceed physiological secretion levels, metabolic pathways may become saturated, significantly prolonging clearance time—this is the core pharmacological basis for the morning residual effect.

When people supplement with exogenous melatonin at night, although they may fall asleep faster in the short term, the artificially elevated hormone levels may "delay" the natural clearance process in the body. This means that by the next morning, residual melatonin concentrations in the blood remain elevated, continuously sending "time to rest" signals to the brain, thereby suppressing the cognitive performance required during wakefulness.

The Molecular Clock of Circadian Rhythm and Melatonin Receptors

To understand why melatonin can have such a profound impact on cognition, we need to understand the underlying mechanisms of circadian rhythm. The body's master biological clock is located in the suprachiasmatic nucleus (SCN) of the hypothalamus, with its molecular basis being a transcription-translation feedback loop composed of a set of core clock genes (such as CLOCK, BMAL1, PER, CRY). The expression of these genes oscillates with an approximately 24-hour periodicity, coordinating rhythmic activities in virtually all tissues throughout the body.

Melatonin influences the clock system by acting on two specific receptors in the SCN: MT1 receptors primarily mediate the acute suppression of neuronal firing (directly promoting drowsiness), while MT2 receptors participate in phase-shifting the biological clock (adjusting rhythm timing). The simultaneous activation of both receptor types by exogenous melatonin may produce undesired rhythm-shifting effects while promoting sleep onset, causing the next morning's wake-up signals to be delayed or weakened.

Healthy Populations Are Also Affected by Melatonin Side Effects

It's worth emphasizing that this study's subjects were "healthy young adults," not patients with sleep disorders. The significance of this design is that even populations with optimal physiological function showed declines in morning cognitive ability after taking melatonin. This suggests that melatonin's negative effects may be relatively universal, rather than limited to specifically sensitive populations.

"Morning cognition" typically encompasses the following key indicators:

• Attention: The ability to concentrate on processing information
• Reaction speed: Response time to external stimuli
• Working memory: The ability to maintain and manipulate information over short periods
• Decision-making ability: Efficiency in analyzing situations and making judgments

In research, these cognitive domains are typically assessed using standardized neuropsychological testing tools, such as the PVT (Psychomotor Vigilance Test) for measuring sustained attention and reaction time, N-back tasks for evaluating performance under working memory load, and the Stroop test for measuring executive control and interference inhibition. These cognitive functions are highly dependent on adequate activation of the prefrontal cortex, which happens to be one of the brain regions most sensitive to sleep-wake transitions. The cognitive impairment observed in the study likely reflects the sustained suppressive effect of residual melatonin on prefrontal cortex arousal signals, similar to a pathologically prolonged version of "sleep inertia."

These abilities are critically important in morning scenarios involving work, study, driving, and other activities—if a person's reactions become slower and attention becomes scattered after taking melatonin, the potential safety risks should not be underestimated.

Melatonin Safety Concerns: Why This Finding Matters

The Gray Area of Supplement Regulation

In many countries, melatonin is classified as a dietary supplement rather than a drug, meaning its dosage, purity, and labeling often lack strict regulation. Commonly available melatonin products range from 0.5 milligrams to 10 milligrams, while research indicates that physiologically effective doses are often far lower than what commercial products list. Excessive intake is one of the key reasons for next-day residual effects and subsequent cognitive impairment.

Notably, melatonin's regulatory status varies enormously worldwide. In the United States, the FDA classifies it as a dietary supplement that can be purchased without a prescription, with no requirement for manufacturers to prove efficacy. In most EU countries (such as the UK and Germany), melatonin is classified as a prescription medication or controlled product. In Australia, melatonin under 2mg was reclassified as an over-the-counter medicine in 2021. The substantive problem created by these regulatory differences is that when sold as a dietary supplement, products are not subject to pharmaceutical GMP (Good Manufacturing Practice) standards. A 2017 study published in the Journal of Clinical Sleep Medicine found that 71% of commercially available melatonin products had actual content that did not match their label claims, with deviations ranging from -83% to +478%, and some products even contained unlabeled serotonin. This means consumers face far more uncertainty in self-medication than expected.

When purchasing, consumers rarely realize that "higher doses don't equal better effects" and may actually worsen the morning "groggy feeling." This cognitive bias is particularly prevalent in self-medication behaviors lacking professional guidance.

Short-Term Sleep Benefits vs. Long-Term Cognitive Costs

Melatonin's appeal lies in its "immediately effective" sleep-onset assistance, but this study reminds us to weigh short-term benefits against potential costs. If you sacrifice an entire morning's cognitive efficiency for an extra half hour of sleep the night before, this "trade" may not be worthwhile.

Especially for the following groups, even minor declines in morning cognition can have substantive impacts:

• Knowledge workers requiring intensive mental effort
• Students facing exams or academic pressure
• Personnel engaged in high-risk operations such as driving or operating machinery
• Managers who need to make important decisions in the morning

Rational Melatonin Usage Guidelines: Scientific Dosing and Timing

Based on this research, we can derive some practical principles for melatonin use:

• Control dosage: Prioritize low-dose (0.5–1 milligram) products and avoid blindly pursuing high doses. Research shows that low-dose melatonin is sufficient to produce sleep-promoting effects while reducing next-day residual risk. It's important to know that the body naturally secretes a total of approximately 0.03 milligrams of melatonin per night, while commercial products typically contain 10 to 300 times that amount—this supraphysiological supplementation itself warrants careful consideration.
• Timing matters: Take it within 30 minutes before bedtime, rather than too early, to reduce the hormone's retention time in the body.
• Avoid long-term dependence: Melatonin is better suited for short-term adjustments (such as jet lag or shift work adaptation) rather than as a long-term solution for chronic insomnia.
• Prioritize natural rhythm adjustment: Improving the sleep environment, controlling evening blue light exposure, and maintaining regular sleep schedules are often more fundamentally effective than supplements. Regarding the impact of blue light, the human retina contains a special class of photoreceptor cells—intrinsically photosensitive retinal ganglion cells (ipRGCs)—that express melanopsin, which is most sensitive to short-wavelength blue light at approximately 460–480 nanometers. When these cells are activated by blue light, signals travel via the retinohypothalamic tract to the SCN, directly suppressing pineal melatonin secretion. The light spectrum emitted by modern electronic device screens happens to be rich in this wavelength band, and sustained evening use can delay melatonin secretion onset by more than 1.5 hours. Therefore, regulating the natural secretion rhythm of endogenous melatonin through light exposure control is often more physiologically sound than directly supplementing exogenous melatonin, and carries absolutely no risk of next-day residual effects.
• Seek professional advice: Before starting use, especially when planning continuous use for more than two weeks, consult a doctor or pharmacist.

Conclusion: A Scientific Perspective on Melatonin's Sleep-Promoting Effects

The value of this research lies not in completely negating melatonin's role, but in breaking the myth that "supplements are harmless." Any substance that intervenes in the body's hormonal system may have chain reactions we have not yet fully grasped. The finding of morning cognitive impairment is precisely a reminder: while pursuing better sleep, we must also take responsibility for our performance during waking hours.

For ordinary consumers, the most rational attitude is to thoroughly understand melatonin's mechanism of action and potential side effects before use, consult a professional doctor when necessary, and not treat it as "candy" that can be casually consumed. After all, truly healthy sleep has never been something that can be solved once and for all with a single pill.